Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors — Ya-Li Sang (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors
Shared by
De Clercq Erik
KU Leuven
Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors
Article
2019
en
Authors
+3 more
YS
Ya-Li Sang
SH
Sheng Han
CP
Christophe Pannecouque
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Xiaomei Chen
,
Qingqing Hao
,
Christophe Pannecouque
,
De Clercq Erik
,
Shuai Wang
,
Fen‐Er Chen
Article
2013
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors
Shiqiong Yang
,
Christophe Pannecouque
,
Dirk Daelemans
,
Xiaodong Ma
,
Yang Liu
,
Fen‐Er Chen
,
De Clercq Erik
Article
2005
Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase
William L. Jorgensen
,
Juliana Ruiz‐Caro
,
Julian Tirado‐Rives
,
Aravind Basavapathruni
,
Karen S. Anderson
,
Andrew D. Hamilton
Bioorganic & Medicinal Chemistry Letters
Article
2008
Non‐Nucleoside HIV‐1 Reverse‐Transcriptase Inhibitors. Part 10
Yueping Wang
,
Fen‐Er Chen
,
Jan Balzarini
,
De Clercq Erik
,
Christophe Pannecouque
Article
2009
Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 13
Yuan‐Zhen Xiong
,
Fen‐Er Chen
,
Jan Balzarini
,
De Clercq Erik
,
Christophe Pannecouque
Discussion(0)
No comments yet. Be the first to comment.